---
title: "Impacting Policy"
featured: false
weight: 15
---

ISARIC4C and CO-CIN (Tier 0) feed data dynamically to Public Health
Scotland, Public Health England, SPI-M, NERVTAG and SAGE. SPI-M have
been highly productive and published several analysis that informed
Policy.

ISARIC4C and CO-CIN data is used to inform the Independent Advisory Group concerning the use of neutralising monoclonal antibodies and anti-viral drugs in high-risk clinical subgroups. 

Other key UK policy documents citing ISARIC4C / CO-CIN data

1.  COVID-19: the green book, chapter 14a.

    a.  cites Docherty AB, et al. Features of 20133 UK patients in
        hospital with covid-19 using the ISARIC WHO Clinical
        Characterisation Protocol: prospective observational cohort
        study <https://doi.org/10.1136/bmj.m1985>

    b.  Swann OV, et al. Clinical Characteristics of children and young
        people admitted to hospital with COVID-19 in United Kingdom:
        prospective multicentre observational cohort study
        <https://doi.org/10.1136/bmj.m3249>

2.  Remdesivir -- national prescribing guidance


